DK3173382T3 - Wolfram(vi)-salte til stimulering af fertilitet og reproduktion og til forbedring af effektiviteten af assisterede reproduktionsteknikker - Google Patents

Wolfram(vi)-salte til stimulering af fertilitet og reproduktion og til forbedring af effektiviteten af assisterede reproduktionsteknikker Download PDF

Info

Publication number
DK3173382T3
DK3173382T3 DK14898173.1T DK14898173T DK3173382T3 DK 3173382 T3 DK3173382 T3 DK 3173382T3 DK 14898173 T DK14898173 T DK 14898173T DK 3173382 T3 DK3173382 T3 DK 3173382T3
Authority
DK
Denmark
Prior art keywords
wolfram
reproduction
effectiveness
salts
improving
Prior art date
Application number
DK14898173.1T
Other languages
English (en)
Inventor
Bugié Agnès Arbat
Almazán Ignacio Canals
Original Assignee
Oxolife Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxolife Sl filed Critical Oxolife Sl
Application granted granted Critical
Publication of DK3173382T3 publication Critical patent/DK3173382T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G41/00Compounds of tungsten
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G41/00Compounds of tungsten
    • C01G41/02Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Powder Metallurgy (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
  • Inorganic Insulating Materials (AREA)
DK14898173.1T 2014-07-21 2014-07-21 Wolfram(vi)-salte til stimulering af fertilitet og reproduktion og til forbedring af effektiviteten af assisterede reproduktionsteknikker DK3173382T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2014/070586 WO2016012632A1 (es) 2014-07-21 2014-07-21 Sales de tungsteno (vi) para su uso en el tratamiento de la infertilidad, para favorecer la fertilidad y la reproducción normal en un mamífero hembra no diabético, así como para mejorar la eficacia de las técnicas de reproducción asistida

Publications (1)

Publication Number Publication Date
DK3173382T3 true DK3173382T3 (da) 2023-03-13

Family

ID=55162540

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14898173.1T DK3173382T3 (da) 2014-07-21 2014-07-21 Wolfram(vi)-salte til stimulering af fertilitet og reproduktion og til forbedring af effektiviteten af assisterede reproduktionsteknikker

Country Status (27)

Country Link
US (1) US10376540B2 (da)
EP (1) EP3173382B1 (da)
JP (1) JP6534439B2 (da)
KR (1) KR102282865B1 (da)
CN (1) CN106715332B (da)
AR (1) AR101252A1 (da)
AU (1) AU2014401750B2 (da)
BR (1) BR112017001287A2 (da)
CA (1) CA2955914C (da)
DK (1) DK3173382T3 (da)
ES (1) ES2940465T3 (da)
FI (1) FI3173382T3 (da)
HR (1) HRP20230223T1 (da)
HU (1) HUE061726T2 (da)
IL (1) IL250212B (da)
LT (1) LT3173382T (da)
MX (1) MX2017000927A (da)
PL (1) PL3173382T3 (da)
PT (1) PT3173382T (da)
RS (1) RS64025B1 (da)
RU (1) RU2679623C2 (da)
SG (1) SG11201700485VA (da)
SI (1) SI3173382T1 (da)
TW (1) TWI709407B (da)
UY (1) UY36222A (da)
WO (1) WO2016012632A1 (da)
ZA (1) ZA201701241B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4368577A1 (en) 2022-11-08 2024-05-15 Oxolife, S.L. Process for the preparation of tungsten (vi) salt hydrates

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2245374B1 (da) * 1973-07-27 1977-02-25 Anvar
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
ES2108642B1 (es) * 1995-07-26 1998-08-16 Quimica Farm Bayer Sa Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.
RU2202314C2 (ru) * 2001-04-11 2003-04-20 Алексей Иванович Ступко Способ подготовки пациентки к искусственному оплодотворению
ES2187276B1 (es) * 2001-05-16 2004-08-01 Quimica Farmaceutica Bayer,S.A. Composiciones orales para el tratamiento de humanos obesos y no diabeticos.
AU2002368261A1 (en) * 2002-10-02 2004-04-23 Yeda Research And Development Co. Ltd. Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
EP1523985B1 (en) * 2003-10-17 2010-03-10 Oy Neurofood Ab Non-radioactive strontium agent for treating cancer
CN102321584B (zh) * 2003-12-31 2014-01-08 宾夕法尼亚州研究基金会 预测并克服对卵巢癌化疗的抗性的方法及预测结肠癌发生的方法
CA2614210A1 (en) * 2005-07-05 2007-01-11 Adelaide Fertility Centre Pty Ltd Methods and compositions for improving pregnancy outcome
JP2009502891A (ja) * 2005-07-29 2009-01-29 ユニベルシダード デ バルセロナ 神経変性疾患、特にアルツハイマー病及び統合失調症の治療のためのタングステン酸塩(vi)を含有してなる製薬的組成物
US20060100154A1 (en) * 2005-10-13 2006-05-11 Yeda Research And Development Co Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
PL2086642T3 (pl) * 2006-10-18 2015-02-27 Periness Ltd DNaza do leczenia męskiej subpłodności
ES2478790B1 (es) * 2013-01-22 2015-05-06 Oxolife, S. L. Uso de sales de tungsteno (VI) para el tratamiento de la infertilidad femenina en mamíferos no diabéticos
ES2551828B1 (es) * 2014-05-21 2016-09-12 Oxolife S.L. Composiciones alimentarias que comprenden sales de tungsteno (VI)

Also Published As

Publication number Publication date
HRP20230223T1 (hr) 2023-04-14
TWI709407B (zh) 2020-11-11
EP3173382A1 (en) 2017-05-31
HUE061726T2 (hu) 2023-08-28
CN106715332B (zh) 2019-01-29
LT3173382T (lt) 2023-03-27
AU2014401750A1 (en) 2017-02-09
AR101252A1 (es) 2016-12-07
PL3173382T3 (pl) 2023-05-08
SI3173382T1 (sl) 2023-04-28
EP3173382B1 (en) 2023-01-04
PT3173382T (pt) 2023-03-10
JP2017523170A (ja) 2017-08-17
CA2955914A1 (en) 2016-01-28
JP6534439B2 (ja) 2019-06-26
ZA201701241B (en) 2022-05-25
FI3173382T3 (fi) 2023-03-25
CN106715332A (zh) 2017-05-24
RU2679623C2 (ru) 2019-02-12
WO2016012632A1 (es) 2016-01-28
RU2017105257A3 (da) 2018-08-21
US10376540B2 (en) 2019-08-13
AU2014401750B2 (en) 2019-10-24
IL250212A0 (en) 2017-03-30
MX2017000927A (es) 2017-05-01
KR102282865B1 (ko) 2021-07-28
SG11201700485VA (en) 2017-02-27
TW201618796A (zh) 2016-06-01
UY36222A (es) 2016-01-29
WO2016012632A9 (es) 2017-05-18
CA2955914C (en) 2022-09-06
BR112017001287A2 (pt) 2018-01-30
ES2940465T3 (es) 2023-05-08
NZ728467A (en) 2021-04-30
RU2017105257A (ru) 2018-08-21
US20170173074A1 (en) 2017-06-22
RS64025B1 (sr) 2023-03-31
KR20170029627A (ko) 2017-03-15
EP3173382A4 (en) 2018-03-21
IL250212B (en) 2020-06-30

Similar Documents

Publication Publication Date Title
DK3295951T3 (da) Anti-pvrig-antistoffer og fremgangsmåder for anvendelse
DK3148579T3 (da) Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf
DK3782639T3 (da) Sammensætninger og fremgangsmåder til internalisering af enzymer
DK3212226T3 (da) Sammensætninger og anvendelsesfremgangsmåder til behandling af metaboliske lidelser
DK3227336T3 (da) Anti-CD79b-antistoffer og fremgangsmåder til anvendelse
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3206493T3 (da) Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
DK3280441T3 (da) Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf
DK3227262T3 (da) Sulfidalkyl og pyridyl-revers-sulfonamidforbindelser til hbv-behandling
DK3183774T3 (da) Indretning og fremgangsmåde til ledning af elektromagnetiske bølger
DK3215532T3 (da) Anti-TIM3-antistoffer og fremgangsmåder til anvendelse
DK3160966T3 (da) Mnk-inhibitorer og fremgangsmåder forbundet dermed
DK3129912T3 (da) Fremgangsmåde og system til sikring af data
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3137605T3 (da) Sammensætninger og fremgangsmåder til modulering af angiopoietin-lignende-3-ekspression
DK3350341T3 (da) Fremgangsmåder til diagnosticering og evaluering af non-alkoholisk steatohepatitis
DK3347015T3 (da) Fremgangsmåder til diagnosticering og behandling af adfærdsforstyrrelser
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
DK3116911T3 (da) Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse
DK3368663T3 (da) Virusfri cellelinjer og fremgangsmåder til opnåelse deraf
DK3177608T3 (da) Proteinkinase-C-hæmmere og fremgangsmåder til anvendelse deraf
DK3200815T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK3253412T3 (da) Anti-cd40l-antistoffer og fremgangsmåder til behandling af cd40l-forbundne sygdomme eller forstyrrelser
DK3393688T3 (da) Fremgangsmåde og indretning til genindvinding af salt